← All organizations
Gracell Biotechnology Ltd.
For profit
Also known as: Gracell Biopharmaceuticals, Inc. | Gracell Biotechnologies Ltd. | Gracell Biotechnologies (Shanghai) Co., Ltd | Gracell Biotechnologies (Shanghai) Co., Ltd. | Gracell Biotechnology Ltd. | Gracell Biotechnology Shanghai Co., Ltd. | Suzhou Gracell Biotechnologies Co., Ltd.
Highest phase reached
Phase 2
First clinical trial
Apr 24, 2018Last known activity
Nov 21, 2025
Acquired by AstraZeneca on Dec 26, 2023
Timeline
2010s
- Jun 1, 2017
Gracell Biotechnology Ltd.— Founded
2020s
- Dec 26, 2023
AstraZeneca— Acquired By
Drugs by trial phase (15 distinct, 35 trials)
Indications
Recent trials (39)
- NCT07249879CollaboratorPhase 1Nov 21, 2025
- NCT07250269CollaboratorPhase 1Oct 29, 2025
- NCT07250269Lead sponsorPhase 1Oct 29, 2025
- NCT07086404CollaboratorEarly Phase 1Sep 15, 2025
- NCT07072884CollaboratorEarly Phase 1Aug 18, 2025
- NCT07058298CollaboratorEarly Phase 1Jul 15, 2025
- NCT06880354CollaboratorPhase 1May 22, 2025
- NCT06759948CollaboratorPhase 1Feb 15, 2025
- NCT06419166CollaboratorEarly Phase 1Dec 1, 2024
- NCT06530849CollaboratorPhase 1/Phase 2Aug 22, 2024
- NCT06530849Lead sponsorPhase 1/Phase 2Aug 22, 2024
- NCT06235229Lead sponsorPhase 1/Phase 2Dec 7, 2023
- NCT06353152CollaboratorPhase 1Nov 17, 2023
- NCT06110208CollaboratorEarly Phase 1Oct 10, 2023
- NCT05850234Lead sponsorPhase 1/Phase 2Jul 20, 2023
Details
- Founded
- Suzhou, CN Jun 1, 2017
- Last known activity
- Nov 21, 2025